Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy.
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.
Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study.
Oracle Cladribine in Early Multiple Sclerisis (MS) (ORACLE MS)
Chronic cladribine administration increases amyloid Beta Peptide generation and plaque burden in mice.
Intas launches biosimilar version of Rituximab
Architecture of human mTOR complex 1.
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial.
Refining diagnosis of multiple sclerosis with revised MRI criteria.
IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
A One Year Follow-Up Study of Natural Killer and Dendritic Cells Activities in Multiple Sclerosis Patients Receiving Glatiramer Acetate (GA).
Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.
Genzyme provides update on U.S. LEMTRADA™ filing
Mitoxantrone-related acute leukemia in MS: An open or closed book?
Glatiramer acetate biases dendritic cells towards an anti-inflammatory phenotype by modulating OPN, IL-17, and RORγt responses and by increasing IL-10 production in experimental allergic encephalomyelitis.
Gordon Research Conference on Glia Biology: Functional Interactions among Glia & Neurons
Results of Phase III BRAVO Trial Reinforce Unique Profile of Laquinimod for Multiple Sclerosis Treatment
Effect of IFN β-1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients.
Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis.
Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: Results of a 17-year longitudinal study.
Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis.
Chemotactic Cytokines: Gordon Research Conference on Molecular and Cellular Mechanisms in Health and Disease
Breastfeeding and multiple sclerosis.
Santhera's Phase III program with Catena®/Raxone® in Duchenne muscular dystrophy on track to deliver pivotal data early in 2Q 2014
Adaptive myelination from fish to man.

Pages